Operating Income (Loss) in USD of Vitro Biopharma, Inc. from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vitro Biopharma, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q2 2025.
  • Vitro Biopharma, Inc. Operating Income (Loss) for the quarter ending July 31, 2025 was -$890K, a 29% increase year-over-year.
  • Vitro Biopharma, Inc. Operating Income (Loss) for the twelve months ending July 31, 2025 was -$5.9M, a 33.8% increase year-over-year.
  • Vitro Biopharma, Inc. annual Operating Income (Loss) for 2024 was -$9.15M, a 70.1% decline from 2023.
  • Vitro Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$5.38M, a 9.8% increase from 2022.
  • Vitro Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$5.97M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$5.9M -$890K +$364K +29% May 1, 2025 Jul 31, 2025 10-Q 2025-09-12
Q1 2025 -$6.26M -$1.08M -$137K -14.4% Feb 1, 2025 Apr 30, 2025 10-Q 2025-06-20
Q4 2024 -$6.12M -$1.85M +$3.03M +62.1% Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-20
Q3 2024 -$9.15M -$2.08M -$245K -13.4% Aug 1, 2024 Oct 31, 2024 10-K 2025-01-28
Q2 2024 -$8.91M -$1.25M -$215K -20.7% May 1, 2024 Jul 31, 2024 10-Q 2025-09-12
Q1 2024 -$8.69M -$946K +$413K +30.4% Feb 1, 2024 Apr 30, 2024 10-Q 2025-06-20
Q4 2023 -$9.11M -$4.87M -$3.72M -324% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-20
Q3 2023 -$5.38M -$1.83M +$565K +23.6% Aug 1, 2023 Oct 31, 2023 10-K 2025-01-28
Q2 2023 -$5.95M -$1.04M +$1.65M +61.3% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 -$7.6M -$1.36M -$765K -129% Feb 1, 2023 Apr 30, 2023 10-Q 2024-05-31
Q4 2022 -$6.83M -$1.15M -$863K -301% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-14
Q3 2022 -$5.97M -$2.4M Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 -$2.69M May 1, 2022 Jul 31, 2022 10-Q 2023-08-28
Q1 2022 -$593K Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-13
Q4 2021 -$287K Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
Q1 2015 -$171K -$53.7K -$8.45K -18.7% Feb 1, 2015 Apr 30, 2015 10-Q 2016-01-22
Q4 2014 -$162K -$28.3K +$8.99K +24.1% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-24
Q3 2014 -$171K -$63.2K Aug 1, 2014 Oct 31, 2014 10-K 2016-09-22
Q2 2014 -$25.3K +$7.71K +23.3% May 1, 2014 Jul 31, 2014 10-Q 2014-09-22
Q1 2014 -$45.2K +$19.6K +30.2% Feb 1, 2014 Apr 30, 2014 10-Q 2016-01-22
Q4 2013 -$37.3K Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-24
Q2 2013 -$33.1K +$5.72K +14.7% May 1, 2013 Jul 31, 2013 10-Q 2014-09-22
Q1 2013 -$64.8K Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-19
Q2 2012 -$38.8K +$9.39K +19.5% May 1, 2012 Jul 31, 2012 10-Q/A 2012-10-17
Q4 2011 -$51.8K +$6.98K +11.9% Nov 1, 2011 Jan 31, 2012 10-Q 2012-03-21
Q2 2011 -$48.2K +$7K +12.7% May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-17
Q4 2010 -$58.8K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q2 2010 -$55.2K May 1, 2010 Jul 31, 2010 10-Q/A 2011-10-12

Vitro Biopharma, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$9.15M -$3.77M -70.1% Nov 1, 2023 Oct 31, 2024 10-K 2025-01-28
2023 -$5.38M +$585K +9.8% Nov 1, 2022 Oct 31, 2023 10-K 2025-01-28
2022 -$5.97M Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2015 -$158K +$12.9K +7.55% Nov 1, 2014 Oct 31, 2015 10-K 2016-09-22
2014 -$171K -$19.7K -13% Nov 1, 2013 Oct 31, 2014 10-K 2016-09-22
2013 -$151K +$27.8K +15.5% Nov 1, 2012 Oct 31, 2013 10-K 2015-02-13
2012 -$179K +$23.3K +11.5% Nov 1, 2011 Oct 31, 2012 10-K 2014-02-12
2011 -$202K +$58.8K +22.5% Nov 1, 2010 Oct 31, 2011 10-K/A 2012-02-16
2010 -$261K Nov 1, 2009 Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.